Filter results
You can narrow down the results using the filters
Audience
Publication type
Topics
Our work
Diseases
9452 results
-
National Implementation Oversight Group – February Communique 2026
The Designated Registered Nurse Prescribing National Implementation Oversight Group meets regularly to guide the roll-out of designated RN prescribing. -
National Implementation Oversight Group – December Communique 2025
The Designated Registered Nurse Prescribing National Implementation Oversight Group meets regularly to guide the roll-out of designated RN prescribing.
-
The Medicare framework
A high-level overview of the Medicare service and claiming process, designed to illustrate how funded services progress through delivery, claiming, payment and compliance activities. -
MPSP Direct Care Targets Trial – single-MPS – Excel reporting template
This template is for participating providers reporting trial information for single MPS. -
Residential aged care homes and the Aged Care Volunteer Visitors Scheme (ACVVS)
This fact sheet outlines the benefits, roles and responsibilities of the Aged Care Volunteer Visitors Scheme (ACVVS) for residential aged care providers. -
Support at Home providers and the Aged Care Volunteer Visitors Scheme (ACVVS)
This fact sheet outlines the benefits, roles and responsibilities of the Aged Care Volunteer Visitors Scheme (ACVVS) for Support at Home providers. -
MPSP Direct Care Targets Trial – care minutes calculator tool guide
This guide provides instructions for using the care minutes calculator tool to support trial reporting. -
New Aged Care Act and ACVVS
This fact sheet outlines the benefits, roles and responsibilities of the Aged Care Volunteer Visitors Scheme (ACVVS) and the New Aged Care Act. -
MPSP Direct Care Targets Trial – care minutes calculator tool
This optional tool helps participating providers calculate direct care and registered nurse minutes for trial reporting. -
MPSP Direct Care Targets Trial – provider endorsement form
This form confirms that the trial information submitted by a provider has been reviewed and authorised. -
MPSP Direct Care Targets Trial – multi-MPS – Excel reporting template
This template is for participating providers reporting trial information for multiple MPS. -
Vaccination dashboards methodology
This page outlines the rules, assumptions and logic that has been applied in developing the four enduring Power BI dashboards. -
Care minutes supplement estimator
This estimator will help non-specialised homes in metropolitan areas estimate how much care minutes supplement they could receive based on care minutes performance. -
Interim ATAGI advice on the administration of RSV - Specific monoclonal antibodies to Aboriginal and Torres Strait Islander infants and children
Interim Australian Technical Advisory Group on Immunisation (ATAGI) advice on the administration of RSV - Specific monoclonal antibodies to Aboriginal and Torres Strait Islander infants and children -
ATAGI statement on counterfeit rabies vaccines and rabies immunoglobulin: Guidance for travellers and healthcare providers
Australian Technical Advisory Group on Immunisation (ATAGI) advice on counterfeit rabies vaccines and rabies immunoglobulin: Guidance for travellers and healthcare providers -
Evaluation of the COAG s19(2) Exemptions Initiative and emerging rural health reform
Read the independent evaluation of the Council of Australian Governments (COAG) s19(2) Exemptions Initiative. -
Frequently asked questions (FAQ) – Hearing Services Program webinar 2026
The Hearing Services Program webinar, published on 29 October 2026, provided an update on current Hearing Services Program activities, upcoming initiatives and key compliance matters. Read responses to questions relating to the topics covered during the webinar. -
Australian Medical Research and Innovation Strategy 2026-2031 and Priorities 2026-2028 consultation report
This document summarises stakeholder feedback on the draft Medical Research Future Fund (MRFF) Strategy for 2026-2031 and Priorities for 2026-2028. -
Australian Medical Research and Innovation Priorities 2026-2028
This document sets out priority areas for investment under the Medical Research Future Fund from 2026 to 2028. It supports the Australian Medical Research and Innovation Strategy 2026-2031 by guiding investment towards areas of greatest need and opportunity. -
Australian Medical Research and Innovation Strategy 2026-2031
This document sets the direction for the Medical Research Future Fund from 2026 to 2031. It outlines the vision, aim and strategic objectives for investment, and the guiding principles that support funding decisions and implementation. -
End-of-Life Pathway Extension information sessions for Support at Home providers #11 – Presentation
Provides guidance to Support at Home providers on arrangements for the End-of-Life Pathway Extension, effective from 8 March 2027, and how to prepare and implement the changes. -
Care minutes and 24/7 registered nurse requirements – guides for registered providers of residential care homes
These guides provide information about the mandatory care minutes and 24/7 registered nurse requirements. Learn more about each requirement, including delivery of care minutes, registered nurse coverage and reporting obligations. -
Certification statement – Sexually Transmissible Infections campaign – Phase 3
This certification statement, signed by Director-General of the Australian Centre for Disease Control, Professor Zoe Wainer on 20 October 2026, certifies that Phase 3 of the Sexually Transmissible Infections campaign complies with relevant guidelines and policies. -
Technical Advisory Group for NDIS functional capacity – Communique – November 2026
Communiqué summarising key discussions, insights and outcomes from the Technical Advisory Group on NDIS Functional Capacity meeting held on 2 November 2026. -
Inclusion Framework 2025–30
Our inclusion framework demonstrates our commitment to fostering a diverse and inclusive workforce that reflects the community we serve. By embracing diverse identities and perspectives, we enrich our organisation and create a culturally safe, accessible, inclusive and respectful workplace.